6/15/2021 7:40:31 AM
Salarius Pharmaceuticals Initiates Phase 1/2 Trial Clinical Trial For Seclidemstat In Hematologic Cancers
1/21/2021 8:13:00 AM
Salarius Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement
1/13/2021 7:37:44 AM
Salarius Receives Second Installment Of $1.7 Mln In Payments From CPRIT